KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.

$22.39  +0.49 (2.24%)
As of 03/05/2021 15:59:49 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
Bermuda
05/24/2018
31,922,546
418,672
$714,107,354
0.00%
SEC Edgar Online
10-Q
10-K
G5269C101
BMG5269C1010
BD0MGM0

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
4.89
0.00
-51.74%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy